Skip to main content

Table 2 Baseline characteristics

From: Image analysis in posttreatment non-small cell lung cancer surveillance: specialists’ interpretations reviewed by the thoracic multidisciplinary tumor board

  Total number of patients
n = 89
PET-CT
n = 45
CE-CT
n = 44
Age, years 65.3 (57.6-73.2) 67.6 (59.8-74.5)* 60.8 (56.6-70.1)*
Gender, female 27 (30.3) 16 (35.6) 11 (25)
Adenocarcinoma 57 (64) 30 (66.7) 27 (61.4)
NSCLC stage
 I 44 (49.4) 21 (46.7) 23 (52.3)
 II 24 (26.9) 14 (31.1) 10 (22.7)
 III 18 (20.2) 8 (17.8) 10 (22.7)
 IVa 3 (3.4) 2 (4.4) 1 (2.3)
Therapy
 Surgery alone 58 (65.2) 31 (68.9) 27 (61.4)
 Surgery + adjuvant chemoth. 19 (21.4) 7 (15.6) 12 (27.3)
 Surgery + neoadjuvant chemoth. 7 (7.8) 4 (8.9) 3 (6.8)
 Radiotherapy +/- chemoth. 2 (2.3) 1 (2.2) 1 (2.3)
 Other 3 (3.4) 2 (4.4) 1 (2.3)
Total number of surveillance studies 266 129 137
  1. Data presented as medians (IQRs) or numbers (%)
  2. PET-CT integrated F-fluorodeoxyglucose positron emission tomography-computed tomography, CE-CT contrast-enhanced computed tomography, NSCLC non-small cell lung cancer
  3. *p = 0.037 PET-CT vs. CE-CT
  4. asolitary brain metastasis